The processing for NHS and epoxy slides is described below

The processing for NHS and epoxy slides is described below. Shotgun glycomics incorporating GSLs and potentially glycoprotein-derived glycans provides an approach to accessing the complex glycomes of animal cells and offers a strategy for focusing structural analyses on functionally significant glycans. Keywords:glycosphingolipids, glycan array, fluorescent labeling, immobilization, functional glycomics == Introduction == Biologically important glycans found in glycosphingolipids and glycoproteins14comprise the complex glycomes of cells and tissues. They are recognized by glycan-binding proteins (GBPs) expressed by human and animal cells, pathogens, and antibodies developed against host and foreign glycans57. Despite enormous progress in high performance liquid chromatography (HPLC), lectin affinity chromatography, mass spectrometry (MS), and glycan microarrays8,9, chemically defining a glycome, the complete list of glycan structures that occur in a cell, tissue, or organism, remains elusive. Because glycan structural analyses are difficult and require specialized technologies, a means of focusing analyses on biologically relevant glycans is desired. Since practical exploration of a cellular glycome should also incorporate quantitative and functional information about glycans, we devised the strategy of Shotgun Glycomics. We derivatize glycans from cellular glycosphingolipids (GSLs) and glycoproteins to generate fluorescently labeled glycans that can be separated, quantified, and covalently printed on glass slides or other surfaces for interrogation by GBPs MMV390048 and antibodies (Fig. 1). This approach is comparable in some ways to shotgun genomics, since the ultimate goal is the elucidation of structures (sequence) and functions of the glycome or genome. == Figure 1. == Schematic for Shotgun glycomics Glycans are released chemically or enzymatically from glycoproteins, GSLs are modified directly; the fluorescently labeled products are separated, quantified, and printed to create microarrays available for interrogation with GBPs. We have developed a fluorescent tag N-(aminoethyl)-2-amino benzamide (AEAB) with an available aryl amine for conjugation to free glycans and an alkyl amine for efficient conjugation to reactive surfaces10. However, a major hurdle to shotgun glycomics and functional glycomics in general is the challenge of derivatizing GSLs. Glycans of GSLs are linked to a sphingosine moiety11, and while enzymatic release of the glycans from GSLs is feasible12, the complete loss of the aglycone may compromise GBP recognition. Therefore, we developed an approach for fluorescently labeling GSLs that permits easy derivatization, quantification, and separation by HPLC, and immobilization to glass slides to generate GSL shotgun microarrays. These microarrays allow interrogation by GBPs and antibodies, permitting structural analyses of GSLs recognized by GBPs. == Results == == Ozonolysis, fluorescent conjugation, printing of GSLs == Ozonolysis of the common sphingosine moiety in GSLs generates a free aldehyde, readily reactive with the heterobifunctionalp-nitrophenyl anthranilate (PNPA)13through reductive amination to form a GSL-PNPA derivative, bearing ap-nitrophenyl ester as an excellent leaving group (Fig. 2a). The derivative precipitates from the product mixture with acetonitrile, and upon reaction MMV390048 with diamines, transforms to a fluorescent labeled GSL derivative, which retains an alkyl amine that can be covalently coupled to appropriate surfaces. == Figure 2. == Fluorescent derivatization of GSLs for shotgun glycomics: (a) The derivatization of GSLs with a bifunctional linker; (b) The C18-HPLC profiles of AOAB derivatization of GM1, MMV390048 GD1a, GT1b and BBG mixture detected by fluorescence; (c) The MALDI-TOF spectra of GM1-AOAB, GD1a-AOAB and GT1b-AOAB purified by HPLC as shown in (b). The spectra were Rabbit Polyclonal to MCL1 acquired in the reflective negative mode; (d) The normal phase HPLC profiles of crude ODA treatment of BBG-PNPA conjugates without precipitation, the precipitate and the filtrate of BBG-PNPA mixture after addition of acetonitrile. The approach was evaluated and optimized using the monosialyl ganglioside GM1 (Gal1-3GalNAc1-4(Neu5Ac2-3)Gal1-4Glc1-ceramide) (Supplementary Fig. 1). We chose NHS-activated slides for further studies, due to their generally lower background, and the ozone, PNPA, and octane-1,8-diamine (ODA) derivatization with its C8extension, due to its relatively higher sensitivity of detection on microarray. We further evaluated this procedure with other GSLs, including GD1a, GT1b, and a mixture of bovine brain gangliosides (BBG) (Fig. 2b-d). C18-HPLC profiles (Fig. 2b) of the products from GM1, GD1a, and GT1b each show a dominant fluorescent peak, suggesting that the reactions are highly specific. No substantial desialylation occurred for individual gangliosides or the BBG mixture based on HPLC. We purified all products by HPLC and characterized them by MALDI-TOF (Fig. 2c) and confirmed all MMV390048 expected masses. We observed partial losses of sialic acids in the MALDI process, especially for.